Today: 20 May 2026
Prudential plc stock slips as $1.2bn buyback kicks off; investors eye March results
7 January 2026
1 min read

Prudential plc stock slips as $1.2bn buyback kicks off; investors eye March results

London, Jan 7, 2026, 09:26 GMT — Regular session

Prudential plc shares slipped in early London trade on Wednesday, pulling back from a fresh 52-week high after the insurer launched a new share buyback. Prudential (PRU.L) was down 1.4% at 1,179 pence, after opening at 1,205 and hitting an intraday low of 1,176; the stock touched 1,213 pence on Tuesday.

Prudential said on Tuesday it would repurchase up to $1.2 billion of ordinary shares, a move that reduces the number of shares in issue and returns cash to shareholders. The programme, scheduled to run until no later than Dec. 18, 2026, includes $500 million of recurring capital returns and $700 million tied to net proceeds from the ICICI Prudential Asset Management IPO, with the remainder earmarked for 2027; the group has said it expects to return more than $5 billion over 2024-2027 before that further IPO-related return. Chief Executive Anil Wadhwani said: “I am pleased with the progress we are making in executing our strategy.” SEC

An announcement on Wednesday showed Prudential has already begun buying shares under the programme, purchasing 316,603 shares on Jan. 6 at an average price of about 1,199.48 pence, with the company set to cancel the shares. Prudential said the buyback cut its issued share capital to about 2.548 billion shares.

The new buyback follows the flotation of Prudential’s Indian asset management joint venture. Prudential sold a 4.5% stake in ICICI Prudential Asset Management ahead of the IPO for about $545 million, and said proceeds from the private placement and the IPO would be returned to shareholders, subject to regulatory and shareholder approvals.

The buyback announcement helped lift the stock in the previous session, after a run that put Prudential near its highs for the year. “Prudential is staging gains thanks to the launch of a $1.2 billion share buyback programme,” said Victoria Scholar, head of investment at interactive investor, in a market note on Tuesday. The Guardian

But the company has flagged limits on how much support the programme can offer in a choppy market. Prudential said there was “no guarantee” the buyback would be completed in full, and that the pace and timing would depend on market conditions and execution considerations. Investegate

Stock Market Today

  • Applied Digital, Viasat, CECO Environmental, and HNI Shares Plunge Amid Rising Yields and Oil Prices
    May 20, 2026, 5:35 PM EDT. Applied Digital (APLD), Viasat, CECO Environmental, and HNI stocks suffered sharp declines in afternoon trading due to surging 10-year Treasury yields hitting 4.56%, a one-year high, and rising WTI crude oil prices near $104 per barrel amid geopolitical tensions. The market also reacted negatively to the lack of concrete agreements from the recent U.S.-China summit. Applied Digital remains notable, trading near its 52-week high at $42.53 after signing long-term AI data center deals expected to generate $7 billion in revenue over 15 years, reflecting strong positioning in the growing AI infrastructure sector. The broader sell-off weighed on major indexes, including the S&P 500 and Nasdaq, pulling them back from record highs.

Latest articles

MicroAlgo Stock Jumped 40%—The Quantum Release Behind MLGO’s Sudden Move

MicroAlgo Stock Jumped 40%—The Quantum Release Behind MLGO’s Sudden Move

20 May 2026
MicroAlgo shares surged 39.95% to $5.36 after the company announced a quantum image-processing algorithm, with volume reaching 9.74 million shares versus a 447,270 average. The stock hit $6.87 intraday before slipping to $5.22 after hours. No customer deals, revenue targets, or product launch dates were disclosed. Market cap stood near $66.7 million at the close.
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
FuelCell Energy surges as AI-fueled rally hits again, analysts wary

FuelCell Energy surges as AI-fueled rally hits again, analysts wary

20 May 2026
FuelCell Energy shares surged 16.5% to $20.22 Wednesday, rebounding after a two-day selloff. The move tracked a 1.5% gain in the Nasdaq Composite and renewed interest in companies supplying power to AI data centers. FuelCell reported a $26.1 million quarterly loss and a declining backlog, despite higher revenue and new data-center proposals. Peers traded mixed, with Bloom Energy up and Plug Power down.
Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says
Previous Story

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
Next Story

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

Go toTop